Showing 8761-8770 of 18119 results for "".
- Transformative Role of Next-Gen Infrared Fluorescence Imaging in Esophageal Surgeryhttps://reachmd.com/news/transformative-role-of-next-gen-infrared-fluorescence-imaging-in-esophageal-surgery/2484859/A team at the University of Hong Kong applied NIR-II fluorescence imaging during esophagectomy to generate real‑time, objective perfusion maps that can change intraoperative decision‑mak
- Therapeutic Advances in IgA Nephropathy: Atacicept and B-Cell Modulationhttps://reachmd.com/news/iga-nephropathy-atacicept-b-cell-modulation/2484843/Atacicept for the treatment of IgAN has entered the FDA accelerated Biologics License Application pathw
- Initiation of PF614 Phase 3 Trial: A New Chapter in Opioid Safetyhttps://reachmd.com/news/pf614-phase-3-trial-opioid-safety/2484846/Ensysce Biosciences has initiated a phase 3 trial of PF614,
- Update on Ianalumab and Eltrombopag: Phase III Findings and Implicationshttps://reachmd.com/news/ianalumab-eltrombopag-phase-iii/2484864/The phase 3 VAYHIT2 trial showed that ianalumab plus eltrombopag meaningfully
- Early-Life Respiratory Infections and Maternal Allergy: Driving Factors in Childhood Asthmahttps://reachmd.com/news/early-life-respiratory-infections-and-maternal-allergy-driving-factors-in-childhood-asthma/2484834/Neonatal RSV exposure combined with maternal allergic disease is associated with a higher risk of childhood asthma—indicating that specific early-life exposures can materially alter la
- Clinical Advances in Retinal Implants: Phase IIb Trial of CPCB-RPE1 for Advanced AMDhttps://reachmd.com/news/clinical-advances-in-retinal-implants-phase-iib-trial-of-cpcb-rpe1-for-advanced-amd/2484862/Regenerative Patch Technologies has launched a Phase IIb trial of the
- Navigating Anesthetic Induction in Critically Ill Patients: Insights on Intubation and Hemodynamicshttps://reachmd.com/news/navigating-anesthetic-induction-in-critically-ill-patients-insights-on-intubation-and-hemodynamics/2484860/A systematic review of induction-agent evidence clarifies how choice of drug alters intubating conditions and cardiovascular risk in critically ill adults. The review
- Advancements in Pretargeted Imaging: Enhancing Tumor Contrast Through Bioorthogonal Chemistryhttps://reachmd.com/news/advancements-in-pretargeted-imaging-enhancing-tumor-contrast-through-bioorthogonal-chemistry/2484824/DZ-Lys-TCO paired with 68Ga-DOTA-H-Tz markedly improves tumor contrast and reduces off-target exposure in preclinical PET/NIRF models—sharpening lesion delineation while lowering systemic radionuclide burden through staged delivery of the targeting vector and radioligand.</
- New Approaches in Female Athlete Injury Prevention: Insights from IOC Guidelineshttps://reachmd.com/news/new-approaches-in-female-athlete-injury-prevention-insights-from-ioc-guidelines/2484829/A consensus statement consolidates 56 female-specific injury‑prevention recommendations that prioritize system-level interventions—policy, environment, equipment and culture—alongside targeted tr
- Beta-lactam Antibiotics and Infant Gut Microbiota: Clinical Implications of Altered Diversityhttps://reachmd.com/news/beta-lactam-antibiotics-and-infant-gut-microbiota-clinical-implications-of-altered-diversity/2484821/Early systemic beta-lactam exposure in term infants was linked to lower gut microbial alpha diversity and selective loss of key commensals that support metabolic and immune development. Antibiotics remain a common response to suspected or confirmed bacterial infectio